{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Vitespen",
  "nciThesaurus": {
    "casRegistry": "492448-75-6",
    "chebiId": "",
    "chemicalFormula": "",
    "definition": "An autologous cancer vaccine derived from tumor-specific gp96 heat shock proteins.  Heat shock proteins chaperone peptides through the endoplasmic reticulum, are key regulators of dendritic cell maturation, migration and antigen processing, and are involved in T-cell activation.",
    "fdaUniiCode": "H3598Y1TLJ",
    "identifier": "C2432",
    "preferredName": "Vitespen",
    "semanticType": "Immunologic Factor",
    "subclassOf": [
      "C1663",
      "C2139"
    ],
    "synonyms": [
      "Autologous gp96 Heat Shock Protein Peptide Complex Vaccine",
      "HSP gp96-Peptide Complex",
      "HSPPC-96",
      "Heat Shock Protein Peptide Complex-96",
      "Oncophage",
      "Recombinant Human Tumor Rejection Antigen 1",
      "VITESPEN",
      "Vitespen",
      "gp96 HSP-Peptide Complex",
      "gp96 HSP-peptide complex",
      "gp96 Heat Shock Protein-Peptide Complex",
      "gp96 heat shock protein-peptide complex vaccine",
      "vitespen"
    ]
  }
}